IL95281A - History of thiazol processes and their preparation and pharmaceutical preparations containing them - Google Patents
History of thiazol processes and their preparation and pharmaceutical preparations containing themInfo
- Publication number
- IL95281A IL95281A IL9528190A IL9528190A IL95281A IL 95281 A IL95281 A IL 95281A IL 9528190 A IL9528190 A IL 9528190A IL 9528190 A IL9528190 A IL 9528190A IL 95281 A IL95281 A IL 95281A
- Authority
- IL
- Israel
- Prior art keywords
- compound
- salt
- mixture
- amino
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/40—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/54—Nitrogen and either oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB898918045A GB8918045D0 (en) | 1989-08-07 | 1989-08-07 | Thiazole derivatives,processes for production thereof and pharmaceutical compositions comprising the same |
GB909003930A GB9003930D0 (en) | 1990-02-21 | 1990-02-21 | Thiazole derivatives,processes for production thereof and pharmaceutical compositions comprising the same |
Publications (2)
Publication Number | Publication Date |
---|---|
IL95281A0 IL95281A0 (en) | 1991-06-30 |
IL95281A true IL95281A (en) | 1996-06-18 |
Family
ID=26295715
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL9528190A IL95281A (en) | 1989-08-07 | 1990-08-03 | History of thiazol processes and their preparation and pharmaceutical preparations containing them |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP0412404B1 (fr) |
JP (1) | JPH0368567A (fr) |
KR (1) | KR910004582A (fr) |
CN (1) | CN1027370C (fr) |
AT (1) | ATE133667T1 (fr) |
AU (1) | AU635758B2 (fr) |
CA (1) | CA2022731A1 (fr) |
DE (1) | DE69025104T2 (fr) |
DK (1) | DK0412404T3 (fr) |
ES (1) | ES2082805T3 (fr) |
FI (1) | FI96857C (fr) |
GR (1) | GR3019009T3 (fr) |
HK (1) | HK151596A (fr) |
HU (2) | HUT57752A (fr) |
IE (1) | IE902679A1 (fr) |
IL (1) | IL95281A (fr) |
NO (1) | NO179638C (fr) |
PH (1) | PH26766A (fr) |
PT (1) | PT94925B (fr) |
RU (2) | RU2010026C1 (fr) |
TW (1) | TW205041B (fr) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU644281B2 (en) * | 1991-04-24 | 1993-12-02 | Sumitomo Pharmaceuticals Company, Limited | Novel thiazole derivatives |
FR2677021B1 (fr) * | 1991-05-31 | 1993-10-01 | Upsa Laboratoires | Nouveaux derives de thiazole antagonistes des recepteurs a l'angiotensine ii; leurs procedes de preparation, compositions pharmaceutiques les contenant. |
DE4119756A1 (de) * | 1991-06-15 | 1992-12-17 | Basf Ag | Aminoalkylsubstituierte 5-mercaptothiazole, ihre herstellung und verwendung |
AT402926B (de) * | 1994-12-05 | 1997-09-25 | Hafslund Nycomed Pharma | Heterocyclische amide, verfahren zu ihrer herstellung und verwendung |
IL117620A0 (en) * | 1995-03-27 | 1996-07-23 | Fujisawa Pharmaceutical Co | Heterocyclic compounds processes for the preparation thereof and pharmaceutical compositions containing the same |
TW513418B (en) * | 1996-07-31 | 2002-12-11 | Otsuka Pharma Co Ltd | Thiazole derivatives, their production and use |
US6262096B1 (en) | 1997-11-12 | 2001-07-17 | Bristol-Myers Squibb Company | Aminothiazole inhibitors of cyclin dependent kinases |
US6414156B2 (en) | 1998-10-21 | 2002-07-02 | Bristol-Myers Squibb Company | Process for preparing azacycloalkanoylaminothiazoles |
US6214852B1 (en) | 1998-10-21 | 2001-04-10 | Bristol-Myers Squibb Company | N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
GB9823871D0 (en) * | 1998-10-30 | 1998-12-23 | Pharmacia & Upjohn Spa | 2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents |
BRPI0009721B8 (pt) | 1999-04-15 | 2021-11-23 | Bristol Myers Squibb Co | Inibidores de tirosina quinase de proteína cíclica |
US7125875B2 (en) | 1999-04-15 | 2006-10-24 | Bristol-Myers Squibb Company | Cyclic protein tyrosine kinase inhibitors |
US6392053B2 (en) | 1999-12-15 | 2002-05-21 | Bristol-Myers Squibb Company | Process for preparing arylacetylaminothiazoles |
US6515004B1 (en) | 1999-12-15 | 2003-02-04 | Bristol-Myers Squibb Company | N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
US6716995B2 (en) | 2000-08-17 | 2004-04-06 | Lumera Corporation | Design and synthesis of advanced NLO materials for electro-optic applications |
EP1347971B1 (fr) | 2000-12-21 | 2006-03-01 | Bristol-Myers Squibb Company | Inhibiteurs thiazolyl des tyrosine kinases de la famille tec |
EP1724270A3 (fr) | 2001-07-19 | 2007-01-03 | Pfizer Italia S.r.l. | Dérivés de phenylacetamido-thiazole, leur procédé de préparation et leur utilisation en tant qu'agents antitumoraux |
EP2314586B1 (fr) | 2002-01-18 | 2016-09-14 | Astellas Pharma Inc. | Dérivé 2-acylaminothiazole ou sel de celui-ci |
EP1647553A4 (fr) | 2003-07-17 | 2008-12-31 | Astellas Pharma Inc | Derive 2-acylaminothiazole ou sel de celui-ci |
JP4774995B2 (ja) * | 2005-01-12 | 2011-09-21 | アステラス製薬株式会社 | アシルアミノチアゾール誘導体を有効成分とする医薬組成物 |
CN101448800A (zh) | 2006-05-31 | 2009-06-03 | 艾博特公司 | 作为大麻素受体配体的新型化合物及其用途 |
US8841334B2 (en) | 2006-05-31 | 2014-09-23 | Abbvie Inc. | Compounds as cannabinoid receptor ligands and uses thereof |
CA2647597A1 (fr) | 2006-05-31 | 2007-12-06 | Abbott Laboratories | Nouveaux composes en tant que ligands des recepteurs des cannabinoides et utilisations de ceux-ci |
WO2008028093A1 (fr) | 2006-08-31 | 2008-03-06 | Abbott Laboratories | Nouveaux composés utilisés comme ligands de récepteurs de cannabinoïde |
US7985768B2 (en) | 2006-08-31 | 2011-07-26 | Abbott Laboratories | Compounds as cannabinoid receptor ligands |
WO2008121558A1 (fr) | 2007-03-28 | 2008-10-09 | Abbott Laboratories | Nouveaux composés en tant que ligands de récepteurs cannabinoïdes |
US7872033B2 (en) | 2007-04-17 | 2011-01-18 | Abbott Laboratories | Compounds as cannabinoid receptor ligands |
WO2008144360A1 (fr) | 2007-05-18 | 2008-11-27 | Abbott Laboratories | Nouveaux composés en tant que ligands de récepteurs cannabinoïdes |
US9193713B2 (en) | 2007-10-12 | 2015-11-24 | Abbvie Inc. | Compounds as cannabinoid receptor ligands |
TWI437986B (zh) * | 2008-01-31 | 2014-05-21 | R Tech Ueno Ltd | 噻唑衍生物及使用該衍生物作為vap-1抑制劑之用途 |
WO2009114566A1 (fr) | 2008-03-11 | 2009-09-17 | Abbott Laboratories | Nouveaux composés en tant que ligands du récepteur de cannabinoïde |
US8846730B2 (en) | 2008-09-08 | 2014-09-30 | Abbvie Inc. | Compounds as cannabinoid receptor ligands |
ES2556752T3 (es) | 2008-09-16 | 2016-01-20 | Abbvie Bahamas Ltd. | Ligandos de receptores cannabinoides |
PA8854001A1 (es) | 2008-12-16 | 2010-07-27 | Abbott Lab | Compuestos novedosos como ligandos de receptores de canabinoides |
CN101768130B (zh) * | 2008-12-30 | 2012-07-04 | 天津药物研究院 | 含氨甲基五元芳香杂环4-羧酸类衍生物、其制备方法和用途 |
CN101768155B (zh) * | 2008-12-30 | 2012-09-05 | 天津药物研究院 | 一类含(氨甲基-五元芳香杂环-4-羰基)-吡咯烷-2-羧酸的衍生物、其制备方法和用途 |
CN104151262B (zh) * | 2014-07-07 | 2016-02-24 | 浙江大学 | 4,5-二取代-2-氨基噻唑化合物及其制备方法 |
CN104163802B (zh) * | 2014-07-08 | 2016-04-27 | 浙江大学 | 2-氨基噻唑-4-甲酸乙酯的制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB951885A (en) * | 1961-05-13 | 1964-03-11 | Sankyo Co | A new process for the preparation of thiazole compounds |
US4649146A (en) * | 1983-01-31 | 1987-03-10 | Fujisawa Pharmaceutical Co., Ltd. | Thiazole derivatives and pharmaceutical composition comprising the same |
-
1990
- 1990-07-16 TW TW079105854A patent/TW205041B/zh active
- 1990-07-19 PH PH40861A patent/PH26766A/en unknown
- 1990-07-23 IE IE267990A patent/IE902679A1/en unknown
- 1990-07-31 AU AU60045/90A patent/AU635758B2/en not_active Ceased
- 1990-07-31 DK DK90114628.2T patent/DK0412404T3/da active
- 1990-07-31 AT AT90114628T patent/ATE133667T1/de not_active IP Right Cessation
- 1990-07-31 ES ES90114628T patent/ES2082805T3/es not_active Expired - Lifetime
- 1990-07-31 EP EP90114628A patent/EP0412404B1/fr not_active Expired - Lifetime
- 1990-07-31 DE DE69025104T patent/DE69025104T2/de not_active Expired - Fee Related
- 1990-08-03 IL IL9528190A patent/IL95281A/en not_active IP Right Cessation
- 1990-08-06 CN CN90106739A patent/CN1027370C/zh not_active Expired - Fee Related
- 1990-08-06 HU HU904912A patent/HUT57752A/hu unknown
- 1990-08-06 PT PT94925A patent/PT94925B/pt not_active IP Right Cessation
- 1990-08-06 KR KR1019900012081A patent/KR910004582A/ko not_active Application Discontinuation
- 1990-08-06 FI FI903879A patent/FI96857C/fi not_active IP Right Cessation
- 1990-08-06 JP JP2208833A patent/JPH0368567A/ja active Pending
- 1990-08-06 CA CA002022731A patent/CA2022731A1/fr not_active Abandoned
- 1990-08-06 RU SU904830691A patent/RU2010026C1/ru active
- 1990-08-06 NO NO903438A patent/NO179638C/no unknown
-
1991
- 1991-11-22 RU SU915010232A patent/RU2048468C1/ru active
-
1995
- 1995-06-22 HU HU95P/P00375P patent/HU211557A9/hu unknown
-
1996
- 1996-02-15 GR GR960400408T patent/GR3019009T3/el unknown
- 1996-08-08 HK HK151596A patent/HK151596A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0412404A3 (en) | 1991-06-12 |
NO903438L (no) | 1991-02-08 |
RU2048468C1 (ru) | 1995-11-20 |
GR3019009T3 (en) | 1996-05-31 |
CN1027370C (zh) | 1995-01-11 |
HK151596A (en) | 1996-08-16 |
HUT57752A (en) | 1991-12-30 |
EP0412404B1 (fr) | 1996-01-31 |
ES2082805T3 (es) | 1996-04-01 |
PH26766A (en) | 1992-09-28 |
EP0412404A2 (fr) | 1991-02-13 |
AU6004590A (en) | 1991-02-07 |
IE902679A1 (en) | 1991-02-27 |
NO179638B (no) | 1996-08-12 |
DE69025104T2 (de) | 1996-07-04 |
HU904912D0 (en) | 1991-01-28 |
FI96857C (fi) | 1996-09-10 |
HU211557A9 (en) | 1995-12-28 |
PT94925A (pt) | 1991-04-18 |
IL95281A0 (en) | 1991-06-30 |
KR910004582A (ko) | 1991-03-29 |
NO179638C (no) | 1996-11-20 |
FI903879A0 (fi) | 1990-08-06 |
CA2022731A1 (fr) | 1991-02-08 |
AU635758B2 (en) | 1993-04-01 |
PT94925B (pt) | 1997-04-30 |
ATE133667T1 (de) | 1996-02-15 |
RU2010026C1 (ru) | 1994-03-30 |
NO903438D0 (no) | 1990-08-06 |
DK0412404T3 (da) | 1996-02-26 |
TW205041B (fr) | 1993-05-01 |
CN1049337A (zh) | 1991-02-20 |
JPH0368567A (ja) | 1991-03-25 |
DE69025104D1 (de) | 1996-03-14 |
FI96857B (fi) | 1996-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL95281A (en) | History of thiazol processes and their preparation and pharmaceutical preparations containing them | |
JP6726226B2 (ja) | 複素環式アミンおよびその使用 | |
KR910007976B1 (ko) | 티아졸 유도체의 제조방법 | |
KR101443795B1 (ko) | 항균성 조성물 | |
US4920129A (en) | Anti-ulcerative imidazopyridine compounds | |
US20080227783A1 (en) | 5-Substituted Thiazol-2-Yl Amino Compounds and Compositions as Protein Kinase Inhibitors | |
JP2009532429A (ja) | 新規ビアリールアミン類 | |
WO2009010871A2 (fr) | Nouveaux dérivés hétéroaryle servant d'antagonistes du récepteur a3 de l'adénosine | |
JP2001508767A (ja) | 5―ht拮抗作用を有するインドール―ウレア誘導体 | |
WO1996030370A2 (fr) | Derives de thiazole et de thiadiazole, leur preparation et compositions pharmaceutiques utiles pour le traitement de la thrombocytopenie | |
SE445642B (sv) | Antiallergiskt och antiastmatiskt verksamma azolopyrimidinoner samt forfarande for deras framstellning | |
US5256675A (en) | Thiazole derivatives, processes for production thereof and pharmaceutical compositions comprising the same | |
US20060084804A1 (en) | Quinazoline thiazolinones | |
JPH11503121A (ja) | アミジン誘導体 | |
EP1797085A1 (fr) | Thiazolinone quinolines 4-monosubstitutes par du thiazolinone | |
AU2003253364A1 (en) | Thiazole derivatives | |
FI60011B (fi) | Foerfarande foer framstaellning av antiflogistiska och blodplaettars aggregering haemmande 4-hydroxi-2h-nafto/2,1-e/-tiazin-3-karboxamid-1,1-dioxider | |
HUT71352A (en) | Heterocyclic derivatives | |
WO2005068458A2 (fr) | Composes inhibiteurs de kinases | |
JP4870164B2 (ja) | ナフチリジン誘導体 | |
JPS6248679A (ja) | カルボスチリル誘導体 | |
KR19990082680A (ko) | 5-ht1a 수용체 리간드로서의 헤테로사이클-에르골린유도체 | |
IE46185B1 (en) | 2,5-dihydro-1,2-thiazino (5,6-b)indol-3-carboxamide-1,1-dioxid derivatives | |
Kwon et al. | The synthesis of 1, 2-benzothiazine-3-carboxamidylhydantoin derivatives and their antiinflammatory and analgesic activities | |
JPS5951544B2 (ja) | チアジン誘導体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
RH | Patent void |